Search Results for: Avandia

Featured Stories

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed.

Read More

Image Source: wisegeek.com

Trial over Ethicon Transvaginal Mesh Begins in California

Pelvic mesh devices have become the subject of safety concerns in recent years amidst reports that they can cause serious, sometimes permanent injuries.

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

J.J. Fuds, Inc. Pet Food Recalled - Listeria Contamination

J.J. Fuds, Inc. Pet Food Recalled Over Potential Listeria Contamination

J.J. Fuds, has recalled a specific lot of its J.J. Fuds Chicken Tender Chunks Pet Food over potential contamination with the dangerous, Listeria monocytogenes pathogen.

Read More

European Regulators Urged to Pull Avandia

We recently wrote that emerging research has added to the growing body of evidence linking the diabetes drug < "http://www.yourlawyer.com/topics/overview/avandia">Avandia (generic: rosiglitazone) to increased adverse health risks. That issue is cardiac, according to the LA Times. Now, the Wall Street … Continue reading

Posted in Avandia, Pharmaceuticals |

Study Sees Same Heart Risks Seen With Actos, Avandia

New research has added to the growing body of evidence linking < "http://www.yourlawyer.com/topics/overview/avandia">Avandia and < "http://www.yourlawyer.com/topics/overview/actos">Actos to increased adverse health risks. This time, the issue is cardiac, said the LA Times. Avandia has long been surrounded with debate concerning cardiovascular … Continue reading

Posted in Avandia, Pharmaceuticals |

Glaxo Under Fire for Avandia Memo

The New York Times is reporting that the credibility of an < "http://www.yourlawyer.com/topics/overview/avandia">Avandia memo from GlaxoSmithKline detailing last month’s advisory panel meeting on the controversial diabetes drug is being attacked. A federal official and some members of that same advisory … Continue reading

Posted in Avandia, Pharmaceuticals |

Questions Over Avandia Disclosures Prompt FDA Probe

< "http://www.yourlawyer.com/topics/overview/avandia">Avandia may be about to cause more trouble for GlaxoSmithKline. According to a report in TIME Magazine, the US Food & Drug Administration (FDA) is trying to determine if Glaxo broke the law when it didn’t disclose data on … Continue reading

Posted in Avandia, Pharmaceuticals |

Another Study Sees Avandia, Actos Fracture Risk

Another study has added to the growing body of evidence linking < "http://www.yourlawyer.com/topics/overview/avandia">Avandia and < "http://www.yourlawyer.com/topics/overview/actos">Actos to an increased risk of fractures. This latest research, which appears in the Journal of Clinical Endocrinology & Metabolism, found that the drugs increased … Continue reading

Posted in Avandia, Pharmaceuticals |

FDA Refers Avandia Panel Conflict Question to HHS

Federal drug regulators have referred a potential conflict-of-interest problem on an < "http://www.yourlawyer.com/topics/overview/avandia">Avandia advisory panel to the inspector general’s office at the Department of Health and Human Services’ (HHS). Earlier this month, the sharply divided Food & Drug Administration (FDA) … Continue reading

Posted in Pharmaceuticals |

Avandia Decision Coming in September, European Regulators Say

European regulators will decide by September if < "http://www.yourlawyer.com/topics/overview/avandia">Avandia will be allowed to stay on the market there. The European Medicines Agency (EMEA) said yesterday that it is still reviewing GlaxoSmithKline’s controversial diabetes drug, which has been linked to an … Continue reading

Posted in Avandia, Pharmaceuticals |

FDA Halts Avandia Study Enrollment

US health regulators have ordered GlaxoSmithKline to stop recruiting patients for an < "http://www.yourlawyer.com/topics/overview/avandia">Avandia trail. The trial, called TIDE (Thiazolidinedione Intervention With Vitamin D Evaluation), was designed to compare the long-term effects of Avandia with another diabetes drug called Actos. … Continue reading

Posted in Avandia, Pharmaceuticals |

FDA Advisor Who Voted in Favor of Avandia Had Ties to Glaxo

One of the members of a government advisory panel who voted to back < "http://www.yourlawyer.com/topics/overview/avandia">Avandia last week was on GlaxoSmithKline’s payroll. According to The Wall Street Journal, Endocrinologist David Capuzzi of Philadelphia is a paid speaker for the drug maker. … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Should Stay on Market, But Restrict Sales, FDA Advisory Panel Says

While < "http://www.yourlawyer.com/topics/overview/avandia">Avandia poses “significant safety concerns,” a sharply divided Food & Drug Administration (FDA) panel voted that the controversial diabetes drug should be allowed to stay on the market. However, the panel of outside experts also said sales of … Continue reading

Posted in Avandia, Pharmaceuticals |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.